Michael Andrew Chambers
CIK: 0001932527
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Sarepta Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct16.9K shares- - Dec 18, 2025SRPT
Sarepta Therapeutics, Inc.
Disposition(D)IndirectConvertible Senior Notes
0 shares- - Dec 18, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)IndirectConvertible Senior Notes
0 shares- - Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct2.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 | SRPT Sarepta Therapeutics, Inc. | Award(A) | 16,875 | - | $0 | Direct |
| Dec 18, 2025 | SRPT Sarepta Therapeutics, Inc. | Disposition(D) Convertible Senior Notes | 0 | - | - | Indirect |
| Dec 18, 2025 | SRPT Sarepta Therapeutics, Inc. | Award(A) Convertible Senior Notes | 0 | - | - | Indirect |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | Award(A) | 2,383 | - | - | Direct |
1-4 of 4 transactions
About Chambers Michael Andrew
Chambers Michael Andrew (SEC CIK 0001932527) files insider reports with the SEC as Director of Sarepta Therapeutics, Inc. (SRPT).
Signal8 holds 3 ownership filings by Chambers Michael Andrew, all Form 4s, filed between Mar 11, 2025 and Jun 5, 2026. Those filings report 4 transactions, from Mar 10, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chambers Michael Andrew's filings is in CAMBRIDGE, MA.
Recent filings by Chambers Michael Andrew
Other insiders filing for Sarepta Therapeutics, Inc. (SRPT)
- Wong Ryan Ho-Yan, Chief Financial Officer
- Estepan Ian Michael, Chief Operating Officer
- Rothfuss Cristin, EVP, General Counsel
- Rodino-Klapac Louise, President, R&D and Tech Ops
- SEVERINO MICHAEL, Chief Executive Officer
- Boor Kathryn Jean, Director